Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommended tool compounds and drugs for blocking P2X and P2Y receptors
Christa E. Müller, Vigneshwaran Namasivayam
Purinergic Signalling (2021) Vol. 17, Iss. 4, pp. 633-648
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Structural insights into the allosteric inhibition of P2X4 receptors
Cheng Shen, Yuqing Zhang, Wenwen Cui, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Species Differences of P2X4 Receptor Modulators
Jessica Nagel, Christiane Bous, Aliaa Abdelrahman, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access | Times Cited: 1
Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology
Adam Oken, Ipsita Krishnamurthy, Jonathan C. Savage, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
Judith Bockstiegel, Jonas Engelhardt, Günther Weindl
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Activation of Adenosine Triphosphate-Gated Purinergic 2 Receptor Channels by Transient Receptor Potential Vanilloid Subtype 4 in Cough Hypersensitivity
Wanzhen Li, Shengyuan Wang, Tongyangzi Zhang, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 285-285
Open Access
UB-MBX-46 is a potent and selective antagonist of the human P2X7 receptor developed by structure-based drug design
Adam Oken, Andreea L. Turcu, Eva Tzortzini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer
Konrad Kurowski, Sophie Nicole Prozmann, António Eduardo Cabrita Figueiredo, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1142-1142
Open Access
ATP, an attractive target for the treatment of refractory chronic cough
Mengru Zhang, Dominic L. Sykes, Laura R. Sadofsky, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 3, pp. 289-305
Open Access | Times Cited: 18
Pharmacological characterization of P2Y receptor subtypes – an update
Ivar von Kügelgen
Purinergic Signalling (2023) Vol. 20, Iss. 2, pp. 99-108
Open Access | Times Cited: 9
The P2X1 receptor as a therapeutic target
Felix M. Bennetts, Jesse I. Mobbs, Sabatino Ventura, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 4, pp. 421-433
Open Access | Times Cited: 15
Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators
Stephanie Weinhausen, Jessica Nagel, Vigneshwaran Namasivayam, et al.
Life Sciences (2022) Vol. 311, pp. 121143-121143
Closed Access | Times Cited: 14
The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
Elena Adinolfi, Elena De Marchi, Marianna Grignolo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13906-13906
Open Access | Times Cited: 7
Chronic cough relief by allosteric modulation of P2X3 without taste disturbance
Chang-Run Guo, Zhong-Zhe Zhang, Xing Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics
Yanshuo Guo, Tianqi Mao, Yafei Fang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist
Jessica Nagel, Olli Törmäkangas, Katja Kuokkanen, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 6, pp. 645-656
Open Access | Times Cited: 2
Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding
Adam Oken, Nicolas E. Lisi, Ismayn A. Ditter, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
P2X3 and P2X2/3 Receptors Inhibition Produces a Consistent Analgesic Efficacy: A Systematic Review and Meta-Analysis of Preclinical Studies
Miguel Á. Huerta, Daniel Marcos-Frutos, Javier de la Nava, et al.
European Journal of Pharmacology (2024) Vol. 984, pp. 177052-177052
Open Access | Times Cited: 2
The P2Y11 receptor of human M2 macrophages activates canonical and IL-1 receptor signaling to translate the extracellular danger signal ATP into anti-inflammatory and pro-angiogenic responses
Dominik Klaver, Hubert Gander, Gerhard Dobler, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 10
Open Access | Times Cited: 11
Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function
Brian F. King
Purinergic Signalling (2022) Vol. 19, Iss. 2, pp. 421-439
Open Access | Times Cited: 9
Methods for studying P2X4 receptor ion channels in immune cells
Ronald Sluyter, Tahnee B.‐D. McEwan, Reece A. Sophocleous, et al.
Journal of Immunological Methods (2024) Vol. 526, pp. 113626-113626
Open Access | Times Cited: 1
Structural insights into the human P2X1 receptor and ligand interactions
Felix M. Bennetts, Hariprasad Venugopal, Alisa Glukhova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
In-Silico Screening to Identify Phytochemical Inhibitor for hP2X7: A Crucial Inflammatory Cell Death Mediator in Parkinson’s Disease
Sabiya Samim Khan, Dharmendra Kumar Khatri
Computational Biology and Chemistry (2024) Vol. 115, pp. 108285-108285
Closed Access | Times Cited: 1
Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release
Jonas Engelhardt, Anna Klawonn, Ann-Kathrin Dobbelstein, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 136-145
Closed Access | Times Cited: 1
P2X receptor antagonists and their potential as therapeutics: a patent review (2010–2021)
Chianna Dane, Leanne Stokes, William T. Jorgensen
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 7, pp. 769-790
Closed Access | Times Cited: 7
P2X receptors: Insights from the study of the domestic dog
Ronald Sluyter, Reece A. Sophocleous, Leanne Stokes
Neuropharmacology (2022) Vol. 224, pp. 109358-109358
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top